Earnings Feed
Sign Up
Home/Filings/4/0001127602-22-003406
4//SEC Filing

Brennan Troyen A 4

Accession 0001127602-22-003406

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:46 PM ET

Size

17.1 KB

Accession

0001127602-22-003406

Insider Transaction Report

Form 4
Period: 2022-02-03
CVS HEALTH CorpCVS
Brennan Troyen A
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2022-02-03$110.00/sh−47,937$5,273,070→ 138,246.059 total
  • Exercise/Conversion

    Stock Option

    2022-02-03−47,937→ 0 total
    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (47,937 underlying)
  • Exercise/Conversion

    Common Stock

    2022-02-03$102.26/sh+47,937$4,902,038→ 186,183.059 total
Holdings

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (84,478 underlying)
    84,478

  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (99,344 underlying)
    99,344

  • Common Stock (restricted)

    4,805

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (53,772 underlying)
    53,772

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (75,134 underlying)
    75,134

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (21,894 underlying)
    21,894

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (80,803 underlying)
    80,803
Footnotes (9)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F2]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2017.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F6]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F7]The number of shares subject to the option were calculated using a 30-day average price.
  • [F8]Options became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F9]Option becomes exercisable in four equal annual installments, commencing 4/1/2022.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001351402

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:46 PM ET
Size
17.1 KB
View on SEC.gov